Metastatic Hormone-sensitive Prostate Cancer (mHSPC) trials recruiting in South Carolina
Fewer than 3 recruiting trials found.
All Metastatic Hormone-sensitive Prostate Cancer (mHSPC) trials nationally
2
Recruiting in South Carolina
2
Cities with sites
Cities in South Carolina
Myrtle Beach 2Charleston 1
Recruiting trials in South Carolina
- Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
- TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)